Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04284267 · ClinicalTrials.gov registry record · NA

Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders

A NA study of Bipolar Disorder, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT04284267 is a NA study of Bipolar Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 56 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04284267, a NA study of Bipolar Disorder, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The investigators are conducting this research study to better understand how individuals with bipolar disorder regulate their emotions, and if transcranial magnetic stimulation (TMS) can help improve emotion regulation for individuals with bipolar mood disorders.

Conditions Studied

Interventions

  • DEVICE Transcranial Magnetic Stimulation

Study Locations (1)

Massachusetts

  • Martinos Center for Biomedical Imaging - Charlestown

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2021-03-01
Est. Completion 2026-03-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04284267

The ClinicalTrials.gov registry entry for NCT04284267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (83% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.

NCT04284267 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04284267 about?

NCT04284267 is a clinical study titled "Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders". The investigators are conducting this research study to better understand how individuals with bipolar disorder regulate their emotions, and if transcranial magnetic stimulation (TMS) can help improve emotion regulation for individuals with bipolar mood disorders.

What is the current status of trial NCT04284267?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2021-03-01. Estimated completion is 2026-03-01.

What conditions does trial NCT04284267 study?

This clinical trial studies the following conditions: Bipolar Disorder.

What interventions are being tested in trial NCT04284267?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04284267?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04284267 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.